APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
Kidney Diseases, Kidney Failure, Kidney Disease, Chronic, Apolopoprotein L1 gene (APOL1), Kidney Transplantation, Kidney Donor, United Network for Organ Sharing (UNOS), Association of Organ Procurement Organizations (AOPO), Kidney Transplantation Outcomes Network, Renal Insufficiency, Chronic Renal Insufficiency, Recipients of a Kidney Transplant, Living Kidney Donors
Lead Scientists at UCSF
- Chi-yuan Hsu, MD
Dr. Hsu has been Chief of the Division of Nephrology at UCSF Health since 2007. He currently holds the Robert W. Schrier Distinguished Professorship in Nephrology. His research spans acute, chronic and end-stage kidney disease and includes both observational studies and clinical trials.
- Meyeon Park, MD
My research focuses on patient outcomes in genetic kidney diseases including polycystic kidney disease and APOL1-mediated kidney disease. I am the medical director of the UCSF PKD Center of Excellence and principal investigator of the UCSF Cardiovascular Risk After Kidney Transplantation (CARAKTER) study.
- accepting new patients
- Start Date
- Completion Date
- Wake Forest University Health Sciences
- Study Type
- Expecting 5000 study participants
- Last Updated